An Overview of Genomic Biomarker Use in Cardiovascular Disease Clinical Trials
- Authors:
-
- Office of Clinical Pharmacology Office of Translational Sciences Center for Drug Evaluation and Research US Food and Drug Administration Silver Spring Maryland USA
- ORISE Fellow Office of Clinical Pharmacology Office of Translational Sciences Center for Drug Evaluation and Research US Food and Drug Administration Silver Spring Maryland USA, Department of Bioengineering Stanford University Palo Alto California USA
- Publication Date:
- Sponsoring Org.:
- USDOE
- OSTI Identifier:
- 1559368
- Resource Type:
- Publisher's Accepted Manuscript
- Journal Name:
- Clinical Pharmacology and Therapeutics
- Additional Journal Information:
- Journal Name: Clinical Pharmacology and Therapeutics Journal Volume: 106 Journal Issue: 4; Journal ID: ISSN 0009-9236
- Publisher:
- Wiley Blackwell (John Wiley & Sons)
- Country of Publication:
- United States
- Language:
- English
Citation Formats
Adeniyi, Oluseyi, Ramamoorthy, Anuradha, Schuck, Robert, Sun, Jielin, Wilson, Jennifer, Zineh, Issam, and Pacanowski, Michael. An Overview of Genomic Biomarker Use in Cardiovascular Disease Clinical Trials. United States: N. p., 2019.
Web. doi:10.1002/cpt.1473.
Adeniyi, Oluseyi, Ramamoorthy, Anuradha, Schuck, Robert, Sun, Jielin, Wilson, Jennifer, Zineh, Issam, & Pacanowski, Michael. An Overview of Genomic Biomarker Use in Cardiovascular Disease Clinical Trials. United States. https://doi.org/10.1002/cpt.1473
Adeniyi, Oluseyi, Ramamoorthy, Anuradha, Schuck, Robert, Sun, Jielin, Wilson, Jennifer, Zineh, Issam, and Pacanowski, Michael. Thu .
"An Overview of Genomic Biomarker Use in Cardiovascular Disease Clinical Trials". United States. https://doi.org/10.1002/cpt.1473.
@article{osti_1559368,
title = {An Overview of Genomic Biomarker Use in Cardiovascular Disease Clinical Trials},
author = {Adeniyi, Oluseyi and Ramamoorthy, Anuradha and Schuck, Robert and Sun, Jielin and Wilson, Jennifer and Zineh, Issam and Pacanowski, Michael},
abstractNote = {},
doi = {10.1002/cpt.1473},
journal = {Clinical Pharmacology and Therapeutics},
number = 4,
volume = 106,
place = {United States},
year = {2019},
month = {6}
}
Free Publicly Available Full Text
Publisher's Version of Record
https://doi.org/10.1002/cpt.1473
https://doi.org/10.1002/cpt.1473
Other availability
Search WorldCat to find libraries that may hold this journal
Save to My Library
You must Sign In or Create an Account in order to save documents to your library.
Works referenced in this record:
Global Requirements for DNA Sample Collections: Results of a Survey of 204 Ethics Committees in 40 Countries
journal, February 2011
- Ricci, D. S.; Broderick, E. D.; Tchelet, A.
- Clinical Pharmacology & Therapeutics, Vol. 89, Issue 4
Occlusion in the Flow of New Drugs for Cardiovascular Disease
journal, June 2017
- Ringel, Ms; Shah, Na; Baedeker, M.
- Clinical Pharmacology & Therapeutics, Vol. 102, Issue 2
Polygenic Risk Score Identifies Subgroup With Higher Burden of Atherosclerosis and Greater Relative Benefit From Statin Therapy in the Primary Prevention Setting
journal, May 2017
- Natarajan, Pradeep; Young, Robin; Stitziel, Nathan O.
- Circulation, Vol. 135, Issue 22
Cardiovascular Drug Development
journal, April 2015
- Fordyce, Christopher B.; Roe, Matthew T.; Ahmad, Tariq
- Journal of the American College of Cardiology, Vol. 65, Issue 15
Open Targets: a platform for therapeutic target identification and validation
journal, November 2016
- Koscielny, Gautier; An, Peter; Carvalho-Silva, Denise
- Nucleic Acids Research, Vol. 45, Issue D1
Genome Sequence Variability Predicts Drug Precautions and Withdrawals from the Market
journal, September 2016
- Lee, Kye Hwa; Baik, Su Youn; Lee, Soo Youn
- PLOS ONE, Vol. 11, Issue 9
Cardiovascular disease: The rise of the genetic risk score
journal, March 2018
- Knowles, Joshua W.; Ashley, Euan A.
- PLOS Medicine, Vol. 15, Issue 3
The support of human genetic evidence for approved drug indications
journal, June 2015
- Nelson, Matthew R.; Tipney, Hannah; Painter, Jeffery L.
- Nature Genetics, Vol. 47, Issue 8
Temporal Trends and Factors Associated With Cardiovascular Drug Development, 1990 to 2012
journal, August 2016
- Hwang, Thomas J.; Lauffenburger, Julie C.; Franklin, Jessica M.
- JACC: Basic to Translational Science, Vol. 1, Issue 5
Clinical development success rates for investigational drugs
journal, January 2014
- Hay, Michael; Thomas, David W.; Craighead, John L.
- Nature Biotechnology, Vol. 32, Issue 1
Scientific and Regulatory Reasons for Delay and Denial of FDA Approval of Initial Applications for New Drugs, 2000-2012
journal, January 2014
- Sacks, Leonard V.; Shamsuddin, Hala H.; Yasinskaya, Yuliya I.
- JAMA, Vol. 311, Issue 4
Tracking the Pharmaceutical Pipeline: Clinical Trials and Global Disease Burden: Tracking the Pharmaceutical Pipeline
journal, May 2014
- Cottingham, Marci D.; Kalbaugh, Corey A.; Fisher, Jill A.
- Clinical and Translational Science, Vol. 7, Issue 4
Pharmaceutical Innovation in the 21st Century: New Drug Approvals in the First Decade, 2000–2009
journal, December 2010
- Kaitin, K. I.; DiMasi, J. A.
- Clinical Pharmacology & Therapeutics, Vol. 89, Issue 2
Landscape of Innovation for Cardiovascular Pharmaceuticals: From Basic Science to New Molecular Entities
journal, July 2017
- Beierlein, Jennifer M.; McNamee, Laura M.; Walsh, Michael J.
- Clinical Therapeutics, Vol. 39, Issue 7
Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations
journal, August 2018
- Khera, Amit V.; Chaffin, Mark; Aragam, Krishna G.
- Nature Genetics, Vol. 50, Issue 9
Genetics and Genomics for the Prevention and Treatment of Cardiovascular Disease: Update: A Scientific Statement From the American Heart Association
journal, December 2013
- Ganesh, Santhi K.; Arnett, Donna K.; Assimes, Themistocles L.
- Circulation, Vol. 128, Issue 25
The State of US Health, 1990-2010: Burden of Diseases, Injuries, and Risk Factors
journal, August 2013
- Murray, Christopher J. L.
- JAMA, Vol. 310, Issue 6
The productivity crisis in pharmaceutical R&D
journal, June 2011
- Pammolli, Fabio; Magazzini, Laura; Riccaboni, Massimo
- Nature Reviews Drug Discovery, Vol. 10, Issue 6
Genetic variations underlying Alzheimer's disease: evidence from genome-wide association studies and beyond
journal, July 2016
- Cuyvers, Elise; Sleegers, Kristel
- The Lancet Neurology, Vol. 15, Issue 8
Current Practices for DNA Sample Collection and Storage in the Pharmaceutical Industry, and Potential Areas for Harmonization: Perspective of the I-PWG
journal, March 2011
- Franc, M. A.; Warner, A. W.; Cohen, N.
- Clinical Pharmacology & Therapeutics, Vol. 89, Issue 4
Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework
journal, May 2014
- Cook, David; Brown, Dearg; Alexander, Robert
- Nature Reviews Drug Discovery, Vol. 13, Issue 6